Tech Company Financing Transactions

Neuronascent Funding Round

Neuronascent, based in Clarksville, received $200 thousand from Maryland Department of Business and Economic Development and private investors.

Transaction Overview

Company Name
Announced On
9/30/2008
Transaction Type
Venture Equity
Amount
$200,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6030 Day Break Cir. A150 - PMB244
Clarksville, MD 21029
USA
Email Address
Overview
Neuronascent is focused on the discovery and development of therapies for Alzheimer's disease, stroke and depression based on the science of neurogenesis that.
Profile
Neuronascent LinkedIn Company Profile
Social Media
Neuronascent Company Twitter Account
Company News
Neuronascent News
Facebook
Neuronascent on Facebook
YouTube
Neuronascent on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Judith Kelleher
  Judith Kelleher LinkedIn Profile  Judith Kelleher Twitter Account  Judith Kelleher News  Judith Kelleher on Facebook
Chief Operating Officer
Kenneth Narducy
  Kenneth Narducy LinkedIn Profile  Kenneth Narducy Twitter Account  Kenneth Narducy News  Kenneth Narducy on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2008: MetaRAM venture capital transaction
Next: 9/30/2008: Arcadia Entertainment venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary